News
We recently published a list of the 11 Most Promising Small-Cap Stocks According to Analysts. In this article, we are going ...
3d
Pharmaceutical Technology on MSNEC grants orphan drug designation to Dyne Therapeutics’ DMD therapyThe company anticipates submitting a biologics licence application for accelerated approval in the US in early 2026.
Shares of Dyne Therapeutics (NASDAQ: DYN) climbed 3.9% following the announcement that the European Commission has granted orphan drug designation to the companys ...
U.K. regulators cleared a multiple myeloma drug GSK withdrew from market three years ago. Elsewhere, RNA editing startup Airna tapped a former Sarepta executive to oversee its pipeline.
Detective shows have garnered a huge demographic thanks to the advent of OTT. An exploration of the human mind and its complexities as showcased effectively through crimes and the investigations to ...
Learn more about whether Alvotech or Sarepta Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Consider these nuts and seeds with fiber: Almonds: 11 grams fiber per 100 grams Pistachios: 7 grams fiber per 100 grams Chia seeds: 9.8 grams fiber per ounce Flaxseed: 2.8 grams fiber per tablespoon ...
ELEVIDYS is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the DMD gene. Infusion-related reactions, including hypersensitivity reactions and anaphylaxis, have occurred ...
Elevidys is indicated for children aged 4-5 years with a confirmed mutation in the DMD gene, except for those with deletions in exon 8 and/or exon 9 in the DMD gene. The Foundation noted that clinical ...
Suneel Ram is a spiritual seeker, sings in a band and was the subject of a comic novel two years ago about living with Duchenne muscular dystrophy, a rare genetic disorder that afflicts one in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results